Christophe Guichard
Chief Executive Officer bei Kh Medtech Sàrl
Profil
Christophe Guichard is currently the Chairman at Neurix SA, Director at Scientis Pharma SA, Director at Kylane Laboratoires SA, Managing Director at Kh Medtech Sàrl, Chief Financial Officer, MD & Partner at Eclosion2 & Cie Scpc since 2008, and Chief Financial Officer at NETRIS Pharma SAS since 2013.
Previously, he worked as a Director at DePGen SA, Chief Financial Officer at Trader Classified Media NV, Audit Manager at Salustro Reydel SA from 1994 to 1998, and Chief Financial Officer at GeNeuro SA (Switzerland) from 2008 to 2015.
He completed his undergraduate degree at École des Hautes Études Commerciales du Nord and his graduate degree at Harvard Business School.
Aktive Positionen von Christophe Guichard
| Unternehmen | Position | Beginn |
|---|---|---|
| Neurix SA | Chairman | - |
| Eclosion2 & Cie Scpc | Director of Finance/CFO | 01.01.2008 |
Kylane Laboratoires SA
 Kylane Laboratoires SA Pharmaceuticals: OtherHealth Technology Kylane Laboratoires SA engages in development of high-end hyaluronic acid and other innovative products in the field of medical beauty. The company is headquartered in Plan-les-Ouates, Switzerland. | Director/Board Member | - |
| Kh Medtech Sàrl | Chief Executive Officer | - |
Scientis Pharma SA
 Scientis Pharma SA Pharmaceuticals: MajorHealth Technology Scientis Pharma SA manufactures pharmaceutical products. The private company is based in Geneva, Switzerland. | Director/Board Member | - |
NETRIS Pharma SAS
 NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Director of Finance/CFO | 01.01.2013 |
Ehemalige bekannte Positionen von Christophe Guichard
| Unternehmen | Position | Ende |
|---|---|---|
| Salustro Reydel SA | Corporate Officer/Principal | 01.01.1998 |
| GENEURO SA | Director of Finance/CFO | 01.11.2015 |
| DePGen SA | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░ ░░░░░ ░░ | ░░░░░░░░ ░░ ░░░░░░░░░░░ | - |
Ausbildung von Christophe Guichard
| École des Hautes Études Commerciales du Nord | Undergraduate Degree |
| Harvard Business School | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GENEURO SA | Health Technology |
| Private Unternehmen | 9 |
|---|---|
Trader Classified Media NV
 Trader Classified Media NV Publishing: Books/MagazinesConsumer Services Trader Classified Media NV provides classified advertising services in vehicles, real estate, employment, and general merchandise. The firm also provides services through the Internet, print, mobile technologies, and direct mail. The company was founded by John H. McCall MacBain in 1987 and is headquartered in Amsterdam, the Netherlands. | Consumer Services |
| Salustro Reydel SA | Commercial Services |
Scientis Pharma SA
Scientis Pharma SA Pharmaceuticals: MajorHealth Technology Scientis Pharma SA manufactures pharmaceutical products. The private company is based in Geneva, Switzerland. | Health Technology |
| Eclosion2 & Cie Scpc | |
| DePGen SA | |
| Neurix SA | |
NETRIS Pharma SAS
NETRIS Pharma SAS BiotechnologyHealth Technology NETRIS Pharma SAS develops targeted therapies for the treatment of cancer. The company is based in Lyon, France. The French company was founded in 2008 by Patrick Mehlen, Agnès Bernet. Patrick Mehlen has been the CEO since 2008. | Health Technology |
Kylane Laboratoires SA
Kylane Laboratoires SA Pharmaceuticals: OtherHealth Technology Kylane Laboratoires SA engages in development of high-end hyaluronic acid and other innovative products in the field of medical beauty. The company is headquartered in Plan-les-Ouates, Switzerland. | Health Technology |
| Kh Medtech Sàrl |
